Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Chronic-Phase × Eicosapentaenoic Acid × Clear all

NCT04006847 2022-07-01

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Phase 1/2 Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase